Fabian Aus dem Siepen

12PUBLICATIONS
51CO-AUTHORS
Gene and molecular therapyAutoimmunityCardiology (incl. cardiovascular diseases)Autonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 22, 2026
Specific treatment of ATTR-CM in Germany-expert consensus of the German Society of Amyloid Diseases (DGAK) and German Cardiac Society (DGK).

|Sep 12, 2026
Phenotypic Considerations for Tafamidis Use in a Real-World Cohort of Older Patients with Transthyretin Amyloid Cardiomyopathy.

|Aug 27, 2026
Survival in a Contemporary, Real-World, Matched Cohort of Patients with Transthyretin Amyloid Cardiomyopathy Treated vs Not Treated with Tafamidis.

|Jun 10, 2026
First-Generation TTR Silencing Therapies in Hereditary Transthyretin Amyloidosis With Polyneuropathy: Real-World Insights From a German Single-Referral Center.

|Nov 13, 2025
Profibrotic Biomarkers Correlate with Clinical Presentation and Outcome in Cardiac Transthyretin Amyloidosis.

Selina J Hein, Fabian Aus dem Siepen, Arnt V Kristen

|Jun 04, 2025
Machine Learning to Automatically Differentiate Hypertrophic Cardiomyopathy, Cardiac Light Chain, and Cardiac Transthyretin Amyloidosis: A Multicenter CMR Study.

Lukas Damian Weberling, Andreas Ochs, Mitchel Benovoy

Pageof 2

Frequent Collaborators

3 joint publications

Stefan Schönland

3 joint publications

Ute Hegenbart

2 joint publications

Angela Dispenzieri

2 joint publications

Pablo Garcia-Pavia